Przejdź do treści
Komórki śródbłonka ludzkiej żyły odpiszczelowej (HSVEC)
Chusteczka
Saphenous vein
Choroba
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Miejsce przerzutów
Not applicable (normal, non-tumorigenic primary cell)
Synonimy
HSaVEC, HSVEC, Human saphenous vein endothelial cells, provitro 1210121

Dokumenty

Komórki śródbłonka ludzkiej żyły odpiszczelowej (HSVEC)

Primary cell · Numer produktu 300699

Venous endothelium for bypass graft research

€1,220.00bez podatku i kosztów wysyłki

Dostosowanie / Zalecenia

Wykonane na zamówienie
1

01Informacje ogólne

Opis

Primary Human Saphenous Vein Endothelial Cells (HSaVEC) are isolated from the saphenous vein and offer a venous endothelial model alongside HUVEC. They are used in research on atherosclerosis, leukocyte adhesion and the endothelial failure of coronary bypass vein grafts.

HSaVEC show the typical cobblestone morphology and express CD31 and VE-cadherin. As cells from adult vessels, they differ from fetal HUVEC: they are more sensitive to oxidized LDL, respond less strongly to cytokines and can present antigen to T cells, making them a closer model of adult venous endothelium.

Chusteczka
Saphenous vein
Choroba
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Miejsce przerzutów
Not applicable (normal, non-tumorigenic primary cell)
Zastosowania
Adult endothelial model: ox-LDL, leukocyte adhesion, antigen presentation and tumor cell adhesion; Endothelial dysfunction in coronary bypass patients, screening of interventions; Mechanobiology: shear stress and arterial-level stretch in vein graft arterialization; Oxidative stress and mitophagy in vein graft failure; Insulin and IGF-1 receptor signaling in type 2 diabetes; Biomaterials: bioactive wound dressings for chronic wounds
Synonimy
  • HSaVEC
  • HSVEC
  • Human saphenous vein endothelial cells
  • provitro 1210121

02Darczyńca

Wiek dawcy
Lot-specific (see CoA)
Pochodzenie etniczne
Lot-specific (see CoA)

03Klasyfikacja

Organizm
Człowiek
Seks
Specyficzne dla partii
Właściwości związane ze wzrostem
Zwolennik
Status GMO
Bez GMO
Szczegółowe informacje dotyczące statusu GMO
No genetic modification; primary human endothelial cells isolated from saphenous vein tissue. Not transformed or immortalized.
Poziom bezpieczeństwa biologicznego
1

04Cechy charakterystyczne

Morfologia
Cobblestone (endothelial)
Typ komórki
Primary endothelial cells
Nowotworotwórczy
No
Czas podwojenia
approx. 24 hours (under optimal EGM-2/EBM-2 conditions, Marelli-Berg et al. 2004)

05Postępowanie i hodowla

Pożywka hodowlana
Endothelial Cell Growth Medium
Atmosfera inkubacyjna

37°C, 5% CO2, saturated humidity.

Suplementy
EGM-2-MV BulletKit supplements: hEGF, VEGF, hFGF-B, IGF-1, hydrocortisone, ascorbic acid, heparin, and 5% FBS (pre-formulated in EGM-2; no additional serum needed). Gelatin-coat culture vessels before seeding.
Odczynnik dysocjacyjny
Subculture reagents as recommended on the certificate of analysis
Powłoka kolby
0.1–0.2% gelatin coating required (incubate gelatin solution 30 min at 37°C, aspirate excess before seeding)
Hodowla komórek w subkulturze

Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

Współczynnik podziału
1 to 3
Gęstość wysiewu
More than 6,000 cells/cm²
Odnawianie płynów
24 hours after seeding, then every 48 to 72 hours
Powrót do stanu sprzed rozmrożenia

Post-thaw viability ≥ 70 % viable cells. More than 80 % confluence within the expected recovery period.

Rozmrażanie i hodowla
  1. Thaw the cryovial quickly in a 37 °C water bath, swirling gently. Just before the last ice has melted, move the vial to a laminar flow hood and decontaminate its outer surface.

  2. Transfer the cell suspension into a 15 ml centrifuge tube, add 10 ml of Endothelial Cell Growth Medium and centrifuge at 250 × g for 5 minutes.

  3. Remove the supernatant and resuspend the cell pellet in 10 ml of Endothelial Cell Growth Medium. Check cell number and viability.

  4. Divide the suspension between two 25 cm² culture flasks (5 ml each). Using two flasks reduces the risk of losing all cells if a passage fails.

  5. Incubate at 37 °C, 5 % CO₂ and saturated humidity, with the screw caps opened by half a turn for gas exchange.

  6. Change the medium after 24 hours to remove unattached cells, then every 48 to 72 hours, using pre-warmed medium only.

  7. Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

  8. Recommended seeding density: more than 6,000 cells/cm².

06Kontrola jakości i kriokonserwacja

Bezpłodność

Mycoplasma contamination is excluded by PCR.

To ensure there is no bacterial, fungal or yeast contamination, cultures are subjected to visual inspection.

Pożywka do zamrażania
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Warunki przechowywania

For long-term preservation, store vials in liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable for up to one week only.

Warunki wysyłki

Cryopreserved primary cells are shipped on dry ice. On receipt, check the cryovial for damage and transfer it without delay to appropriate storage.

07Ekspresja i podatność

Antygeny powierzchniowe
CD31 (PECAM-1); VE-cadherin (CD144); von Willebrand factor (vWF); eNOS; HLA-DR (inducible); ICAM-1 (inducible); VCAM-1 (inducible); E-selectin (inducible); UEA-I lectin binding
Receptory ulegające ekspresji
VEGFR2 (KDR); VEGFR1; TIE-2; EGFR (low)

08Identyfikatory

Źródło
Human saphenous vein endothelial cells (HSVEC) (Cytion catalog number 300699)
Numer identyfikacji podatkowej NCBI
9606
Cellosaurus
Not assigned